Skip to main content

Table 1 Quality assessment of randomized clinical trials with JBA tool

From: Effect of bromocriptine on glycemic control, risk of cardiovascular diseases and weight in patients with type 2 diabetes: a systematic review

Studies

Answers

Yes

No

Unclear

NA

Aminorroaya et al. [5]

*

   

Chamarthi et al. [8]

*

   

Chamarthi et al. [9]

*

   

Cincotta et al. [12]

*

   

Chamarthi and Cincotta [16]

*

   

Pijl et al. [1]

*

   

Gaziano et al. [11]

*

   

Gaziano et al. [2]

*

   
  1. Ratings scales are based on the parameters: (1) was true randomization used for assignment of participants to treatment groups? (2) Was allocation to treatment groups concealed? (3) Were treatment groups similar at the baseline? (4) Were participants blind to treatment assignment? (5) Were those delivering treatment blind to treatment assignment? (6) Were outcomes assessors blind to treatment assignment? (7) Were treatment groups treated identically other than the intervention of interest? (8) Was follow up complete and if not, were differences between groups in terms of their follow up adequately described and analyzed? (9) Were participants analyzed in the groups to which they were randomized? (10) Were outcomes measured in the same way for treatment groups? (11) Were outcomes measured in a reliable way? (12) Was appropriate statistical analysis used? (13) Was the trial design appropriate and any deviations from the standard RCT design (individual randomization, parallel groups) accounted for in the conduct and analysis of the trial?
Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us